Journal of Cardiovascular Magnetic Resonance (Jan 2013)

European cardiovascular magnetic resonance (EuroCMR) registry – multi national results from 57 centers in 15 countries

  • Bruder Oliver,
  • Wagner Anja,
  • Lombardi Massimo,
  • Schwitter Jürg,
  • van Rossum Albert,
  • Pilz Günter,
  • Nothnagel Detlev,
  • Steen Henning,
  • Petersen Steffen,
  • Nagel Eike,
  • Prasad Sanjay,
  • Schumm Julia,
  • Greulich Simon,
  • Cagnolo Alessandro,
  • Monney Pierre,
  • Deluigi Christina C,
  • Dill Thorsten,
  • Frank Herbert,
  • Sabin Georg,
  • Schneider Steffen,
  • Mahrholdt Heiko

DOI
https://doi.org/10.1186/1532-429X-15-9
Journal volume & issue
Vol. 15, no. 1
p. 9

Abstract

Read online

Abstract Background The EuroCMR registry sought to evaluate indications, image quality, safety and impact on patient management of clinical routine CMR in a multi-national European setting. Furthermore, interim analysis of the specific protocols should underscore the prognostic potential of CMR. Methods Multi-center registry with consecutive enrolment of patients in 57 centers in 15 countries. More than 27000 consecutive patients were enrolled. Results The most important indications were risk stratification in suspected CAD/Ischemia (34.2%), workup of myocarditis/cardiomyopathies (32.2%), as well as assessment of viability (14.6%). Image quality was diagnostic in more than 98% of cases. Severe complications occurred in 0.026%, always associated with stress testing. No patient died during or due to CMR. In 61.8% CMR findings impacted on patient management. Importantly, in nearly 8.7% the final diagnosis based on CMR was different to the diagnosis before CMR, leading to a complete change in management. Interim analysis of suspected CAD and risk stratification in HCM specific protocols revealed a low rate of adverse events for suspected CAD patients with normal stress CMR (1.0% per year), and for HCM patients without LGE (2.7% per year). Conclusion The most important indications in Europe are risk stratification in suspected CAD/Ischemia, work-up of myocarditis and cardiomyopathies, as well as assessment of viability. CMR imaging is a safe procedure, has diagnostic image quality in more than 98% of cases, and its results have strong impact on patient management. Interim analyses of the specific protocols underscore the prognostic value of clinical routine CMR in CAD and HCM. Condensed abstract The EuroCMR registry sought to evaluate indications, image quality, safety and impact on patient management of clinical routine CMR in a multi-national European setting in a large number of cases (n > 27000). Based on our data CMR is frequently performed in European daily clinical routine. The most important indications in Europe are risk stratification in suspected CAD/Ischemia, work-up of myocarditis and cardiomyopathies, as well as assessment of viability. CMR imaging is a safe procedure, has diagnostic image quality in more than 98% of cases, and its results have strong impact on patient management. Interim analyses of the specific protocols underscore the prognostic value of clinical routine CMR in CAD and HCM.

Keywords